• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成在孤立性骨浆细胞瘤中的预后价值

Prognostic value of angiogenesis in solitary bone plasmacytoma.

作者信息

Kumar Shaji, Fonseca Rafael, Dispenzieri Angela, Lacy Martha Q, Lust John A, Wellik Linda, Witzig Thomas E, Gertz Morie A, Kyle Robert A, Greipp Philip R, Rajkumar S Vincent

机构信息

Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Blood. 2003 Mar 1;101(5):1715-7. doi: 10.1182/blood-2002-08-2441. Epub 2002 Oct 17.

DOI:10.1182/blood-2002-08-2441
PMID:12393501
Abstract

Angiogenesis plays an important role in the biology of multiple myeloma (MM) and has prognostic importance in this disease. Solitary plasmacytoma is a localized plasma cell malignancy that progresses to MM in a significant number of patients. We examined if angiogenesis is increased in solitary plasmacytoma and if it can help identify patients likely to progress to myeloma. We studied angiogenesis in plasmacytoma biopsy samples and bone marrow biopsies from 25 patients. High-grade angiogenesis was present in 64% of plasmacytomas. In contrast, bone marrow angiogenesis was low in all patients. Patients with high-grade angiogenesis in the plasmacytoma sample were more likely to progress to myeloma and had a shorter progression-free survival compared with patients with low-grade angiogenesis (P =.02). Angiogenesis is increased in solitary plasmacytoma and is a significant predictor of progression to myeloma and provides further evidence of its importance in the pathogenesis of myeloma.

摘要

血管生成在多发性骨髓瘤(MM)生物学中起重要作用,且对该疾病具有预后意义。孤立性浆细胞瘤是一种局限性浆细胞恶性肿瘤,相当一部分患者会进展为MM。我们研究了孤立性浆细胞瘤中血管生成是否增加,以及它是否有助于识别可能进展为骨髓瘤的患者。我们研究了25例患者的浆细胞瘤活检样本和骨髓活检中的血管生成情况。64%的浆细胞瘤存在高级别血管生成。相比之下,所有患者的骨髓血管生成均较低。与低级别血管生成的患者相比,浆细胞瘤样本中存在高级别血管生成的患者更有可能进展为骨髓瘤,且无进展生存期更短(P = 0.02)。孤立性浆细胞瘤中血管生成增加,是进展为骨髓瘤的重要预测指标,并为其在骨髓瘤发病机制中的重要性提供了进一步证据。

相似文献

1
Prognostic value of angiogenesis in solitary bone plasmacytoma.血管生成在孤立性骨浆细胞瘤中的预后价值
Blood. 2003 Mar 1;101(5):1715-7. doi: 10.1182/blood-2002-08-2441. Epub 2002 Oct 17.
2
Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study.骨孤立性浆细胞瘤的预后因素:一项多中心罕见癌症网络研究。
BMC Cancer. 2006 May 5;6:118. doi: 10.1186/1471-2407-6-118.
3
Solitary plasmacytoma: is radiation therapy sufficient?孤立性浆细胞瘤:放射治疗是否足够?
Am J Hematol. 2008 Sep;83(9):695-6. doi: 10.1002/ajh.21248.
4
Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.孤立性骨浆细胞瘤:放疗后的结局及预后因素
Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):1063-7. doi: 10.1016/s0360-3016(98)00186-2.
5
Solitary plasmacytoma of bone: treatment, progression, and survival.骨孤立性浆细胞瘤:治疗、进展与生存
J Clin Oncol. 1987 Nov;5(11):1811-5. doi: 10.1200/JCO.1987.5.11.1811.
6
Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group-Sarcoma Working Party.浆细胞瘤的临床及预后特征:土耳其肿瘤学组-肉瘤工作组的多中心研究
Am J Hematol. 2008 Sep;83(9):702-7. doi: 10.1002/ajh.21211.
7
Radiotherapy in the treatment of solitary plasmacytoma.放射治疗在孤立性浆细胞瘤治疗中的应用
Br J Radiol. 1997 May;70(833):511-6. doi: 10.1259/bjr.70.833.9227234.
8
Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.放疗后骨髓瘤蛋白持续存在超过一年是骨孤立性浆细胞瘤的不良预后因素。
Cancer. 2002 Mar 1;94(5):1532-7. doi: 10.1002/cncr.10366.
9
Reossification and prognosis following radiotherapy with/without surgery for spinal solitary plasmacytoma of the bone: a retrospective study of 39 patients.放疗联合/不联合手术治疗脊柱单发骨浆细胞瘤:39 例回顾性研究。
Spine J. 2020 Feb;20(2):283-291. doi: 10.1016/j.spinee.2019.09.018. Epub 2019 Sep 20.
10
Plasmacytoma. Treatment results and conversion to myeloma.浆细胞瘤。治疗结果及转化为骨髓瘤的情况。
Cancer. 1992 Mar 15;69(6):1513-7. doi: 10.1002/1097-0142(19920315)69:6<1513::aid-cncr2820690633>3.0.co;2-x.

引用本文的文献

1
Association between radiotherapy and overall survival or cancer-specific survival in patients with solitary plasmacytoma of bone at pre-B cell grade: a real-world study using the SEER database.前B细胞分级的骨孤立性浆细胞瘤患者放疗与总生存期或癌症特异性生存期之间的关联:一项使用监测、流行病学和最终结果(SEER)数据库的真实世界研究
Ann Hematol. 2025 Apr;104(4):2461-2468. doi: 10.1007/s00277-025-06347-5. Epub 2025 Apr 14.
2
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.细胞遗传学异常对孤立性骨浆细胞瘤疾病进展风险的影响。
Blood. 2023 Nov 30;142(22):1871-1878. doi: 10.1182/blood.2023021187.
3
A Case of Recurrent Multiple Myeloma as Testicular Plasmacytoma Without Systemic Disease.
一例复发性多发性骨髓瘤表现为睾丸浆细胞瘤且无系统性疾病
Cureus. 2023 Jun 22;15(6):e40785. doi: 10.7759/cureus.40785. eCollection 2023 Jun.
4
Solitary Plasmacytoma in the Calcaneus.跟骨孤立性浆细胞瘤
Cureus. 2023 Apr 16;15(4):e37637. doi: 10.7759/cureus.37637. eCollection 2023 Apr.
5
Anti-Angiogenic Activity of Drugs in Multiple Myeloma.药物在多发性骨髓瘤中的抗血管生成活性。
Cancers (Basel). 2023 Mar 27;15(7):1990. doi: 10.3390/cancers15071990.
6
What's Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma.旧药新用:沙利度胺在多发性骨髓瘤现代治疗中的过去、现在和未来作用。
Target Oncol. 2022 Jul;17(4):383-405. doi: 10.1007/s11523-022-00897-8. Epub 2022 Jun 30.
7
Prediction of Solitary Plasmacytoma of Bone in Elderly Patients: A Nomogram and a Risk Classification System for Overall Survival.老年患者孤立性骨浆细胞瘤的预测:总生存的列线图和风险分类系统。
Biomed Res Int. 2022 Jun 1;2022:7387416. doi: 10.1155/2022/7387416. eCollection 2022.
8
A Rare Case of Solitary Plasmacytoma Arising From the Sternum.一例罕见的起源于胸骨的孤立性浆细胞瘤
Cureus. 2022 Apr 4;14(4):e23819. doi: 10.7759/cureus.23819. eCollection 2022 Apr.
9
Potential of a sphingosine 1-phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment.1-磷酸鞘氨醇受体拮抗剂和鞘氨醇激酶抑制剂作为多发性骨髓瘤治疗靶点的潜力。
Oncol Lett. 2022 Apr;23(4):111. doi: 10.3892/ol.2022.13231. Epub 2022 Feb 8.
10
Extramedullary plasmacytoma of the ureter.输尿管髓外浆细胞瘤
IJU Case Rep. 2021 Sep 16;5(1):19-22. doi: 10.1002/iju5.12373. eCollection 2022 Jan.